21505_Demystifying Hypertriglyceridemia: Taking a Closer Look at Pathophysiology, Etiology, and Trea

Eliot Brinton, MD and Terry Jacobson, MD discuss the pathophysiology, etiology, and treatment of hypertriglyceridemia.

Hypertriglyceridemia is a commonly encountered clinical condition which reflects the accumulation in plasma of proatherogenic lipoproteins, triglyceride-rich lipoprotein remnants, and small, dense LDL particles. It is caused by interactions between many genetic and nongenetic factors, and is associated with atherosclerotic cardiovascular disease, and at very high levels, acute pancreatitis. In this program, experts will address the educational needs of internists related to hypertriglyceridemia management: 1) awareness of risks and complications associated with hypertriglyceridemia, 2) identification of treatment options for elevated triglycerides, 3) similarities and differences between fish oil supplements and prescription omega-3 treatments, and between omega-3 prescription agents, and 4) more precise definition of patient populations for incorporation of triglyceride-lowering therapies based on evidence-based data and clinical practice guidelines.

Login to your Account